NCT06871410 2026-03-24Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRoswell Park Cancer InstitutePhase 1 Recruiting26 enrolled
NCT05526924 2026-03-04Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck CancerUniversity of ChicagoPhase 1 Recruiting30 enrolled
NCT06005324 2025-06-08Personalized, Adaptive Treatment for Locally Advanced Head and Neck CancerUniversity of ChicagoPhase 1 Recruiting36 enrolled